Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | CYP1A2 |
| Upstream (Parents) |
|---|
| (<<) ALPPL2 → CYP1A2 |
| (<<) BMPR2 → CYP1A2 |
| (<<) CHSY1 → CYP1A2 |
| (<<) CTGF → CYP1A2 |
| (<<) DHRS9 → CYP1A2 |
| (<<) DNAJA4 → CYP1A2 |
| (<<) E2F4 → CYP1A2 |
| (<<) EMILIN2 → CYP1A2 |
| (<<) GNRH2 → CYP1A2 |
| (<<) GYPC → CYP1A2 |
| (<<) INE1 → CYP1A2 |
| (<<) ITGAV → CYP1A2 |
| (<<) KCNJ5 → CYP1A2 |
| (<<) KLF2 → CYP1A2 |
| (<<) KLK3 → CYP1A2 |
| (<<) KRT1 → CYP1A2 |
| (<<) LCP1 → CYP1A2 |
| (<<) LRCH4 → CYP1A2 |
| (<<) MAP3K4 → CYP1A2 |
| (<<) MAPK11 → CYP1A2 |
| (<<) MMP17 → CYP1A2 |
| (<<) MPP1 → CYP1A2 |
| (<<) NAB2 → CYP1A2 |
| (<<) OBSCN → CYP1A2 |
| (<<) PIK3R5 → CYP1A2 |
| (<<) PIM1 → CYP1A2 |
| (<<) PIP4K2A → CYP1A2 |
| (<<) PLA2G6 → CYP1A2 |
| (<<) PPP1R11 → CYP1A2 |
| (<<) PSORS1C2 → CYP1A2 |
| (<<) RAB15 → CYP1A2 |
| (<<) RAP1A → CYP1A2 |
| (<<) RHBDL1 → CYP1A2 |
| (<<) RPL23A → CYP1A2 |
| (<<) RPS12 → CYP1A2 |
| (<<) SLC25A37 → CYP1A2 |
| (<<) SMAD5 → CYP1A2 |
| (<<) SULF1 → CYP1A2 |
| (<<) THBS1 → CYP1A2 |
| (<<) TMPRSS11D → CYP1A2 |
| Downstream (Children) |
|---|
| CYP1A2 → CDH22 (>>) |
| CYP1A2 → DRD4 (>>) |
| CYP1A2 → E2F2 (>>) |
| CYP1A2 → EPHB6 (>>) |
| CYP1A2 → GNB2L1 (>>) |
| CYP1A2 → GRIN2D (>>) |
| CYP1A2 → HDAC5 (>>) |
| CYP1A2 → HLA-DOA (>>) |
| CYP1A2 → JAK3 (>>) |
| CYP1A2 → LIMK1 (>>) |
| CYP1A2 → PTPN12 (>>) |
| CYP1A2 → ZNF224 (>>) |
